Human p53R2 Antibody
R&D Systems, part of Bio-Techne | Catalog # AF3788
Key Product Details
Species Reactivity
Validated:
Cited:
Applications
Validated:
Cited:
Label
Antibody Source
Product Specifications
Immunogen
Met1-Lys180
Accession # Q7LG56
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human p53R2 Antibody
Detection of Human p53R2 by Western Blot.
Western blot shows lysates of HEK293 human embryonic kidney cell line and U2OS human osteosarcoma cell line. PVDF membrane was probed with 1 µg/mL of Human p53R2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF3788) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF017). A specific band was detected for p53R2 at approximately 45 kDa (as indicated). This experiment was conducted using Immunoblot Buffer Group 1.Detection of p53R2 by Western Blot
Gemcitabine resistance is driven by RRM1 overexpression. A) Quantification of relative RRM1 mRNA abundance following shRNA-mediated knock-down in BxPC3, BxGR-80C and BxGR-360C cells. Three independent RNA samples analyzed per cell type. b) Relative gemcitabine IC50 values following RRM1 knock-down, normalized to the control for each subclone. c) Correlation between relative RRM1 mRNA abundance and absolute gemcitabine (GEM) IC50 for all RRM1 knock-down cells and controls. d) Western blotting of dose-dependent induction of an RRM1 band with the apparent mass of 110–120 kDa (RRM1*) and RRM2 in gemcitabine treated cells. a-b) Statistical significance tested using one-way ANOVA with Tukey’s multiple comparison test. Error-bars indicate standard error of the mean. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35617275), licensed under a CC-BY license. Not internally tested by R&D Systems.Detection of p53R2 by Western Blot
Gemcitabine resistance is driven by RRM1 overexpression. A) Quantification of relative RRM1 mRNA abundance following shRNA-mediated knock-down in BxPC3, BxGR-80C and BxGR-360C cells. Three independent RNA samples analyzed per cell type. b) Relative gemcitabine IC50 values following RRM1 knock-down, normalized to the control for each subclone. c) Correlation between relative RRM1 mRNA abundance and absolute gemcitabine (GEM) IC50 for all RRM1 knock-down cells and controls. d) Western blotting of dose-dependent induction of an RRM1 band with the apparent mass of 110–120 kDa (RRM1*) and RRM2 in gemcitabine treated cells. a-b) Statistical significance tested using one-way ANOVA with Tukey’s multiple comparison test. Error-bars indicate standard error of the mean. Image collected and cropped by CiteAb from the following open publication (https://pubmed.ncbi.nlm.nih.gov/35617275), licensed under a CC-BY license. Not internally tested by R&D Systems.Applications for Human p53R2 Antibody
Western Blot
Sample: HEK293 human embryonic kidney cell line and U2OS human osteosarcoma cell line
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: p53R2
The p53-inducible ribonucleotide reductase (p53R2) shares similarity with the R2 subunit of ribonucleotide reductase. Both function to provide dNTPs for DNA synthesis. p53R2 is induced in response to genotoxic stress, whereas the R2 functions under homeostatic conditions. When the expression of p53R2 is decreased, cells exhibit decreased ribonucleotide reductase activity, DNA repair activity, and cellular survival in response to genotoxins.
Alternate Names
Gene Symbol
UniProt
Additional p53R2 Products
Product Documents for Human p53R2 Antibody
Product Specific Notices for Human p53R2 Antibody
For research use only